Quantum-Si Highlights Significant Development Advancements for Proteus™ and Industry Leading Technology Pipeline at Investor & Analyst Day

BRANFORD, Conn.--(BUSINESS WIRE)--Quantum-Si Highlights Significant Development Advancements for ProteusTM and Industry Leading Technology Pipeline at Investor & Analyst Day.

Business Wire • Nov 20, 2025

Quantum-Si incorporated (QSI) Analyst/Investor Day Transcript

Quantum-Si incorporated ( QSI ) Analyst/Investor Day November 19, 2025 10:00 AM EST Company Participants Jeffrey Hawkins - President, CEO & Director Todd Rearick - Chief Technology Officer John Vieceli - Chief Product Officer Brian Reed Conference Call Participants Kyle Mikson - Canaccord Genuity Corp., Research Division Swayampakula Ramakanth - H.C. Wainwright & Co, LLC, Research Division Scott Henry - Alliance Global Partners, Research Division Puneet Souda - Leerink Partners LLC, Research Division Presentation Jeffrey Hawkins President, CEO & Director All right.

Seeking Alpha • Nov 19, 2025

Quantum-Si to Highlight Significant Proteus™ Platform Development Progress and Provide Insights into the Company's Industry Leading Technology Pipeline at Investor & Analyst Day

BRANFORD, Conn.--(BUSINESS WIRE)--QSI to Highlight Significant Proteus™ Platform Dev Progress & Provide Insights into Company's Industry Leading Tech Pipeline at Investor & Analyst Day.

Business Wire • Nov 19, 2025

Quantum-Si incorporated (QSI) Q3 2025 Earnings Call Transcript

Quantum-Si incorporated ( QSI ) Q3 2025 Earnings Call November 5, 2025 4:30 PM EST Company Participants Risa Lindsay Jeffrey Hawkins - President, CEO & Director Jeffry Keyes - CFO & Treasurer Conference Call Participants Alexander Vukasin - Canaccord Genuity Corp., Research Division Scott Henry - Alliance Global Partners, Research Division Swayampakula Ramakanth - H.C. Wainwright & Co, LLC, Research Division Presentation Operator Good day, and thank you for standing by.

Seeking Alpha • Nov 6, 2025

Quantum-Si Reports Third Quarter 2025 Financial Results

BRANFORD, Conn.--(BUSINESS WIRE)--Quantum-Si Reports Third Quarter 2025 Financial Results. Announces Successful Sequencing on Prototype Proteus Unit, Development Program is On-Track.

Business Wire • Nov 5, 2025

Quantum-Si Incorporated (QSI) Reports Q3 Loss, Lags Revenue Estimates

Quantum-Si Incorporated (QSI) came out with a quarterly loss of $0.17 per share in line with the Zacks Consensus Estimate. This compares to a loss of $0.18 per share a year ago.

Zacks Investment Research • Nov 6, 2025

Quantum-Si to Participate in the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum

BRANFORD, Conn.--(BUSINESS WIRE)--Quantum-Si to Participate in the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum.

Business Wire • Oct 20, 2025

Quantum-Si to Report Third Quarter 2025 Financial Results on November 5, 2025

BRANFORD, Conn.--(BUSINESS WIRE)--Quantum-Si to Report Third Quarter 2025 Financial Results on November 5, 2025.

Business Wire • Oct 13, 2025

Why Quantum-Si Stock Flopped on Friday

Quantum-Si's (QSI -4.02%) shares weren't quite the picture of health as the trading week came to an end. Investors, concerned about the healthcare technology company potentially making dilutive secondary share issues, traded out of the stock to leave it with a nearly 5% loss on the day.

The Motley Fool • Oct 10, 2025

Quantum-Si to Host Investor & Analyst Event in New York City on November 19, 2025

BRANFORD, Conn--(BUSINESS WIRE)--Quantum-Si to Host Investor & Analyst Event in New York City on November 19, 2025.

Business Wire • Sep 23, 2025